Stockreport

Cryo-Cell Announces Plans to Explore Strategic Alternatives and Spin-off Celle Corp. to Maximize Shareholder Value

Cryo-Cell International, Inc.  (CCEL) 
NASDAQ:AMEX Investor Relations: cryo-cell.com/investor-relations
PDF OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the “Company” or “Cryo-Cell”), the world’s first private cord blood bank to [Read more]